S&P 500   3,141.63 (+0.29%)
DOW   27,911.30 (+0.11%)
QQQ   204.98 (+0.53%)
AAPL   270.77 (+0.85%)
FB   202.26 (+0.69%)
MSFT   151.70 (+0.38%)
GOOGL   1,344.25 (+0.10%)
AMZN   1,748.72 (+0.55%)
CGC   20.25 (+0.80%)
NVDA   217.34 (+1.57%)
MU   49.26 (+3.79%)
BABA   204.64 (+2.09%)
GE   10.97 (-0.36%)
TSLA   352.70 (+1.11%)
T   38.17 (+0.29%)
AMD   39.47 (+0.08%)
ACB   2.45 (-2.78%)
F   9.11 (+0.44%)
PRI   135.45 (+0.13%)
NFLX   298.93 (+1.98%)
BAC   33.64 (+0.33%)
GILD   67.78 (+1.04%)
DIS   147.59 (+1.02%)
S&P 500   3,141.63 (+0.29%)
DOW   27,911.30 (+0.11%)
QQQ   204.98 (+0.53%)
AAPL   270.77 (+0.85%)
FB   202.26 (+0.69%)
MSFT   151.70 (+0.38%)
GOOGL   1,344.25 (+0.10%)
AMZN   1,748.72 (+0.55%)
CGC   20.25 (+0.80%)
NVDA   217.34 (+1.57%)
MU   49.26 (+3.79%)
BABA   204.64 (+2.09%)
GE   10.97 (-0.36%)
TSLA   352.70 (+1.11%)
T   38.17 (+0.29%)
AMD   39.47 (+0.08%)
ACB   2.45 (-2.78%)
F   9.11 (+0.44%)
PRI   135.45 (+0.13%)
NFLX   298.93 (+1.98%)
BAC   33.64 (+0.33%)
GILD   67.78 (+1.04%)
DIS   147.59 (+1.02%)
S&P 500   3,141.63 (+0.29%)
DOW   27,911.30 (+0.11%)
QQQ   204.98 (+0.53%)
AAPL   270.77 (+0.85%)
FB   202.26 (+0.69%)
MSFT   151.70 (+0.38%)
GOOGL   1,344.25 (+0.10%)
AMZN   1,748.72 (+0.55%)
CGC   20.25 (+0.80%)
NVDA   217.34 (+1.57%)
MU   49.26 (+3.79%)
BABA   204.64 (+2.09%)
GE   10.97 (-0.36%)
TSLA   352.70 (+1.11%)
T   38.17 (+0.29%)
AMD   39.47 (+0.08%)
ACB   2.45 (-2.78%)
F   9.11 (+0.44%)
PRI   135.45 (+0.13%)
NFLX   298.93 (+1.98%)
BAC   33.64 (+0.33%)
GILD   67.78 (+1.04%)
DIS   147.59 (+1.02%)
S&P 500   3,141.63 (+0.29%)
DOW   27,911.30 (+0.11%)
QQQ   204.98 (+0.53%)
AAPL   270.77 (+0.85%)
FB   202.26 (+0.69%)
MSFT   151.70 (+0.38%)
GOOGL   1,344.25 (+0.10%)
AMZN   1,748.72 (+0.55%)
CGC   20.25 (+0.80%)
NVDA   217.34 (+1.57%)
MU   49.26 (+3.79%)
BABA   204.64 (+2.09%)
GE   10.97 (-0.36%)
TSLA   352.70 (+1.11%)
T   38.17 (+0.29%)
AMD   39.47 (+0.08%)
ACB   2.45 (-2.78%)
F   9.11 (+0.44%)
PRI   135.45 (+0.13%)
NFLX   298.93 (+1.98%)
BAC   33.64 (+0.33%)
GILD   67.78 (+1.04%)
DIS   147.59 (+1.02%)
Log in

AMEX:EHC - Encompass Health Stock Price, Forecast & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume620,391 shs
Average Volume618,344 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Facilities
SectorN/A
CUSIP42192430
Phone+1-205-9677116

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings Date2/6/2020 (Estimated)
OptionableOptionable

Receive EHC News and Ratings via Email

Sign-up to receive the latest news and ratings for EHC and its competitors with MarketBeat's FREE daily newsletter.


Encompass Health (AMEX:EHC) Frequently Asked Questions

What is Encompass Health's stock symbol?

Encompass Health trades on the AMEX under the ticker symbol "EHC."

How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health?

Encompass Health announced a quarterly dividend on Tuesday, July 23rd. Shareholders of record on Tuesday, October 1st will be paid a dividend of $0.28 per share on Tuesday, October 15th. This represents a $1.12 dividend on an annualized basis and a yield of ∞. The ex-dividend date is Monday, September 30th. View Encompass Health's Dividend History.

How were Encompass Health's earnings last quarter?

Encompass Health Corp (AMEX:EHC) released its earnings results on Monday, October, 28th. The company reported $0.93 EPS for the quarter, beating analysts' consensus estimates of $0.89 by $0.04. The company had revenue of $1.16 billion for the quarter, compared to analysts' expectations of $1.15 billion. Encompass Health's revenue was up 8.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.91 earnings per share. View Encompass Health's Earnings History.

When is Encompass Health's next earnings date?

Encompass Health is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Encompass Health.

What guidance has Encompass Health issued on next quarter's earnings?

Encompass Health updated its FY19 earnings guidance on Monday, October, 28th. The company provided earnings per share (EPS) guidance of $3.71-3.85 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.82. The company issued revenue guidance of $4.5-4.6 billion, compared to the consensus revenue estimate of $4.58 billion.

What price target have analysts set for EHC?

11 equities research analysts have issued twelve-month price objectives for Encompass Health's shares. Their forecasts range from $68.00 to $77.00. On average, they expect Encompass Health's share price to reach $73.11 in the next twelve months. View Analyst Price Targets for Encompass Health.

What is the consensus analysts' recommendation for Encompass Health?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last year. There are currently 1 sell rating, 1 hold rating and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Encompass Health.

Has Encompass Health been receiving favorable news coverage?

News articles about EHC stock have been trending negative this week, InfoTrie reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Encompass Health earned a daily sentiment score of -2.6 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an impact on the stock's share price in the near future. View News Stories for Encompass Health.

Who are some of Encompass Health's key competitors?

What other stocks do shareholders of Encompass Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include NVIDIA (NVDA), Activision Blizzard (ATVI), Illumina (ILMN), Netflix (NFLX), Walmart (WMT), Costco Wholesale (COST), Starbucks (SBUX), Tesla (TSLA), Ford Motor (F) and Advanced Micro Devices (AMD).

Who are Encompass Health's key executives?

Encompass Health's management team includes the folowing people:
  • Mark J. Tarr, President, Chief Executive Officer (Age 55)
  • Douglas E. Coltharp, Chief Financial Officer, Executive Vice President (Age 55)
  • April Anthony, Chief Executive Officer and President - Encompass (Age 50)
  • Cheryl B. Levy, Chief Human Resource Officer (Age 58)
  • Patrick Darby, Executive Vice President, General Counsel, Secretary (Age 52)
  • Barbara A. Jacobsmeyer, Executive Vice President - Operations (Age 51)
  • Edmund M. Fay, Senior Vice President, Treasurer (Age 50)
  • Andrew L. Price CPA, Chief Accounting Officer (Age 50)
  • Elissa Joy Charbonneau, Chief Medical Officer (Age 57)
  • Leo I. Higdon Jr., Non-Executive Independent Chairman of the Board (Age 71)

How do I buy shares of Encompass Health?

Shares of EHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Encompass Health's official website?

The official website for Encompass Health is http://www.healthsouth.com/.

How can I contact Encompass Health?

Encompass Health's mailing address is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. The company can be reached via phone at +1-205-9677116 or via email at [email protected]


MarketBeat Community Rating for Encompass Health (AMEX EHC)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  404 (Vote Outperform)
Underperform Votes:  281 (Vote Underperform)
Total Votes:  685
MarketBeat's community ratings are surveys of what our community members think about Encompass Health and other stocks. Vote "Outperform" if you believe EHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/11/2019 by MarketBeat.com Staff

Featured Article: Retained Earnings

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel